Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100164Source: DataRank Database

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements is a research paper published in Drug and Alcohol Dependence Reports (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.66)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Jeffery Talbert ORCID,Robert Bohler ORCID,Jordan Kelsch,Christopher Cook ORCID,Derek Blevins ORCID

Live enrichment

PubMed:37234704 PMC:PMC10206439 OpenAlex:https://openalex.org/W4367693337

Columbia University

Grant: R01GM987654

Columbia University

Grant: UM1DA049394

National Institutes of Health

Grant: UM1DA049412

National Institutes of Health

Grant: UM1DA049415

National Institutes of Health

Grant: UM1DA049406

National Institutes of Health

Grant: 3UM1DA049412-03S2

MassHEAL - Reducing overdose deaths by 40% (2019-2023)

National Institutes of Health

Grant: 1UM1DA049415-01

CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State

National Institutes of Health

Grant: 3UM1DA049394-01S1

HEALing Communities Study Data Coordinating Center Supplement

National Institutes of Health

Grant: 5UM1DA049406-02

Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)

FWCI

5.66

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.dadr.2023.100164

publisherhttps://doi.org/10.1016/j.dadr.2023.100164

publisherhttps://api.elsevier.com/content/article/PII:S2772724623000343?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772724623000343?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37234704

Fields of Study

Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes03 medical and health sciences0305 other medical science

Keywords

WaiverBuprenorphineState (computer science)Federal stateMedicineComputer scienceLawPolitical scienceOpioidPublic administrationInternal medicineProgramming languagePolicyTreatment BarriersOpioid Use Disorder TreatmentData WaiverFull Length ReportR

Sustainable Development Goals

SDG 0: Good health and well-being

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

FAIR Checklist

Authors (13)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)